August 14, 2012Drugs/Medicineadmin WALTHAM, Mass., Aug. 14, 2012 /PRNewswire/ -- GeNO LLC ( www.genollc.com ), a privately held pharmaceutical company developing a line of inhaled nitric oxide drug products, today announced that the U.S. ...
